z-logo
Premium
Acceleration of bone formation during fracture healing by injectable collagen powder and human basic fibroblast growth factor containing a collagen‐binding domain from Clostridium histolyticum collagenase
Author(s) -
Saito Wataru,
Uchida Kentaro,
Ueno Masaki,
Matsushita Osamu,
Inoue Gen,
Nishi Nozomu,
Ogura Takayuki,
Hattori Shunji,
Fujimaki Hisako,
Tanaka Keisuke,
Takaso Masashi
Publication year - 2014
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.34974
Subject(s) - collagenase , basic fibroblast growth factor , materials science , bone healing , fibroblast , wound healing , biomedical engineering , growth factor , fibroblast growth factor , biophysics , biochemistry , medicine , chemistry , immunology , surgery , biology , enzyme , receptor , in vitro
Growth factor delivered with implantable biomaterials has been used to both accelerate and ensure healing of open fractures in human patients. However, a major limitation of implantable biomaterials is the requirement for open surgical placement. Here, we developed an injectable collagen material‐based bone formation system consisting of injectable collagen powder with fibril morphology and collagen triple helix conformation, and basic fibroblast growth factor (bFGF) fused to the collagen‐binding domain (CBD) of Clostridium histolyticum collagenase. The affinity of the CBD towards collagen was confirmed by the results of collagen‐binding assays. Moreover, the combination of the collagen binding‐bFGF fusion protein (CB‐bFGF) with injectable collagen powder induced bone formation at protein concentrations lower than those required for bFGF alone in mice fracture models. Taken together, these properties suggest that the CB‐bFGF/collagen powder composite is a promising injectable material for bone repair in the clinical setting. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3049–3055, 2014.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here